Orchid Pharma share price target for 2022 2023 2024 2025 2030

Orchid Pharma share price target

In this article we discuss about Orchid Pharma share price target for the year 2022 2023 2024 2025 2030. Get a stocks price prediction.

About Orchid Pharma :

Orchid Pharma Ltd. turned into included in the yr 1992. Its contemporary share price is 371.15. Its current marketplace capitalisation stands at Rs 1514.9 Cr. inside the contemporary sector, organisation has suggested Gross sales of Rs. 4506.95 Cr and overall profits of Rs.4571.7 Cr. The agency‘s control includes Nikita okay, Manoj Kumar Goyal, Mudit Tandon, Dharam Vir, Tanu Singla, Arun Kumar Dhanuka, Mridul Dhanuka, Manish Dhanuka, Ram Gopal Agarwal.

Mkt cap1.51TCr
52-wk high2,654.25
52-wk low365.00

Share Target Price 2022 2023 2025 2030 of alembic ltd

Show 102550100 entriesSearch:

Yeartarget 1target 2

FAQ – Orchid Pharma Share Price Target

Is ORCHID PHARMA appropriate for long time investment?
As on 04-Feb-2022, the basics of ORCHID PHARMA appearance poor and therefore it could no longer be precise for long time investment ! See financial overall performance of ORCHID PHARMA . Please look at the other parameters including Valuation, fee Momentum, information & company Governance and/or consult an funding marketing consultant before taking an investment choice!

Is ORCHID PHARMA UnderValued or overrated?
As on 04-Feb-2022, ORCHID PHARMA is Over Valued based on the estimates of intrinsic cost and as a result might not be an awesome buying possibility consistent with share Valuation right now!

what’s the Intrinsic fee of ORCHID PHARMA ?
As on 04-Feb-2022, the Intrinsic price of ORCHID PHARMA is Rs. 286.37 decided primarily based on Median of the three ancient fashions.
truthful value [Median EV / EBIDTA Model] : Rs. 809.59
truthful cost [Median EV / Sales Model] : Rs. 286.37
truthful fee [Median Price / Sales Model] : Rs. 18.34
Median honest price of ORCHID PHARMA : Rs. 286.37

Is ORCHID PHARMA buying and selling at a top rate or cut price?
As on 04-Feb-2022, ORCHID PHARMA is buying and selling at a premium of 30% based totally at the estimates of Median Intrinsic cost!

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top